MTOR and neoplasm: In a mouse sarcoma model, it has been demonstrated that increased glycolysis and thus glucose consumption in tumor cells metabolically restricts T lymphocytes by reducing mTOR activity, glycolytic capacity, and interferon (IFN)-γ production in these cells [160].